Arabesque Asset Management’s Pfizer PFE Stock Holding History

Arabesque Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-96,213	Closed	-$4.93M	–	99
2022 Q4	$4.93M	Buy	96,213 +43,810	+84%	+$2.1M	1.67%	3
2022 Q3	$2.29M	Buy	52,403 +7,161	+16%	+$348K	1.12%	24
2022 Q2	$2.37M	Sell	45,242 -27,588	-38%	-$1.41M	1.25%	12
2022 Q1	$3.77M	Buy	72,830 +27,825	+62%	+$1.44M	1.31%	16
2021 Q4	$2.66M	Buy	+45,005	New	+$2.23M	0.77%	41
2019 Q1	–	Sell	-5,677	Closed	-$235K	–	106
2018 Q4	$235K	Buy	+5,677	New	+$236K	0.23%	67

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Arabesque Asset Management's PFE Position: Q1 2023 in Review

Arabesque Asset Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 96,213 shares — an estimated $4.93M sold.

Arabesque Asset Management first reported a position in PFE in Q4 2018 and held it in 6 quarters. The position peaked at $4.93M in Q4 2022. 3,105 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Arabesque Asset Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Arabesque Asset Management sold 96,213 Pfizer shares in Q1 2023, an estimated $4.93M.
Arabesque Asset Management first reported a position in Pfizer in Q4 2018 and held it in 6 quarters.
Arabesque Asset Management's Pfizer position peaked at $4.93M in Q4 2022.
3,105 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Arabesque Asset Management's 13F filing for Q1 2023.